Keiichiro Nojiri

Tsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The safety and efficacy of Ringer's solution loading with rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: The RESOLUTION-PEP study.

The safety and efficacy of Ringer's solution loading with rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: The RESOLUTION-PEP study.

Journal: DEN open

Published: December 16, 2022

Second and third-look endoscopy for the prevention of post-ESD bleeding.

Second and third-look endoscopy for the prevention of post-ESD bleeding.

Journal: Medicine

Published: February 13, 2015

Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression.

Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression.

Journal: International journal of oncology

Published: March 18, 2014

Corrigendum: Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression.

Corrigendum: Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression.

Journal: International journal of oncology

Published: March 18, 2014

The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis.

The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis.

Journal: Molecular medicine reports

Published: July 09, 2013

Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.

Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.

Journal: Anticancer research

Published: November 17, 2012

The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.

The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.

Journal: Oncology reports

Published: September 18, 2012

Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.

Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.

Journal: International journal of oncology

Published: June 11, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026